Drug profile · INN
melatonin
SLENYTO
melatonin (SLENYTO) is a melatonin receptor agonist. Associated with Lacuna Pharma Pty Ltd.
EMA: approved TGA: approved Nervous system (N05) N05CH01
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — melatonin
- Class
- Nervous system (N05)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.83
Quick answer
melatonin (SLENYTO) is a melatonin receptor agonist. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN melatonin
Brand SLENYTO
Mechanism Melatonin receptor agonist
Target Melatonin receptor
Therapeutic class Nervous system (N05)
ATC code N05CH01
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Melatonin receptor agonist
Primary target: Melatonin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is melatonin?
melatonin (SLENYTO) is a melatonin receptor agonist. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for melatonin?
SLENYTO is a marketed brand name for melatonin. Check FDA Drugs@FDA for the current US label holder and prescribing information.